Updated 5/2/17. The results chart includes audits where the findings have been finalized. Remaining audits are still under review. Information on Corrective Action Plans and Sanctions will be updated once approved by HRSA. HRSA recommends covered entities do not contact audited manufacturers regarding sanctions until a corrective action plan has been approved by HRSA and posted on this website.
|Manufacturer||State||OPA Findings||Sanction||Corrective Action Status||Manufacturer Contact Information|
|Celgene||NJ||No adverse findings||None||N/A|
|Valeant Pharmaceuticals, Inc.||NJ||No adverse findings||None||N/A|
|Leading Pharma, LLC||NJ||No adverse findings||None||N/A|
|Hospira, Inc.||IL||No adverse findings||None||N/A|
|Fresenius Kabi||IL||No adverse findings||None||N/A|